Ioannis F. Voutsas

Tumor-Specific CD4+ T Lymphocytes from Cancer Patients Are Required for Optimal Induction of Cytotoxic T Cells Against the Autologous Tumor

Constantin N. Baxevanis, Ioannis F. Voutsas, Ourania Tsitsilonis et al. · The Journal of Immunology · 2000 · 161 citations · Full text

T-regulatory Cell, Immunology, Autologous Tumor +18

Compromised anti-tumor responses in tumor necrosis factor-α knockout mice

Constantin N. Baxevanis, Ioannis F. Voutsas, Ourania Tsitsilonis et al. · European Journal of Immunology · 2000 · 79 citations · Full text

Inflammation, Cancer Immunosurveillance, Autoimmune Disease +14

Ii-Key/HER-2/neu(776-90) hybrid peptides induce more effective immunological responses over the native peptide in lymphocyte cultures from patients with HER-2/neu+ tumors

Nectaria N. Sotiriadou, Nikoletta L. Kallinteris, Angelos D. Gritzapis et al. · Cancer Immunology Immunotherapy · 2006 · 52 citations · Full text

Tumor Immunology, Her-2/neu+ Tumors, Cancer Immunosurveillance +11

Induction of potent CD4⁺ T cell‐mediated antitumor responses by a helper HER‐2/<i>neu</i> peptide linked to the Ii‐Key moiety of the invariant chain

Ioannis F. Voutsas, Angelos D. Gritzapis, Louisa G. Mahaira et al. · International Journal of Cancer · 2007 · 47 citations

Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/ <i>neu</i> with Potent Antitumor Properties

Angelos D. Gritzapis, Ioannis F. Voutsas, Eftychia Lekka et al. · The Journal of Immunology · 2008 · 32 citations · Full text